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Wen-Chung Wang1 and Yen-Chein Lai2*Abstract
Granulosa cell tumors are rare ovarian malignancies. Their characteristics include unpredictable late recurrent and
malignant behavior. Recent molecular studies have characterized the FOXL2 402C > G mutation in adult-type
granulosa cell tumor. In this study, we report an 80-year-old woman with a granulosa cell tumor arising from ovary.
She presented with a huge pelvic mass with postmenopausal bleeding. No obvious intraperitoneal tumor implants
were observed during operation. Final diagnosis was granulosa-theca cell tumor without capsule invasion. No
recurrent disease was noted during 3-year post-operation follow-up period. Molecular studies showed a
heterozygous FOXL2 402C > G mutation in the tumor by direct gene sequencing. In addition, DNA replication error,
on analysis of the lengths of CAG repeats in androgen receptor gene, revealed defective DNA mismatch repair
system in the granulosa cell tumor. We propose that the 402C > G mutation in FOXL2 is critical to the development
of adult granulosa cell tumor. However, the malignant behavior of this tumor is driven by DNA mismatch repair
deficiency. Unequal DNA copy numbers were noted on array comparative genomic hybridization. This implies that
there is malignant potential even in the early stage of the granulosa cell tumor. Late malignant recurrence may be
a late event of DNA repair function disability, not directly related to pathognomonic FOXL2 mutation.
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Sex cord-stromal tumors represent approximately 8% of
all ovarian tumors [1]. The incidence is about 0.2 per
100000 women. The most frequently diagnosed tumor
type within sex cord-stromal category is the granulosa
cell tumor [1]. Granulosa cell tumors may be composed
almost exclusively of granulosa cells, but more commonly
also contain theca cells, lutein cells, and/or fibroblasts [2].
The granulosa cells in tumor may be arranged in trabecu-
lar, insular, grand like, microfollicular, macrofollicular or
diffuse cellular patterns [3]. Granulosa cell tumors can be
further categorized into two distinct subtypes, juvenile
and adult forms [1]. Juvenile granulosa cell tumor is char-
acterized by a modular or diffuse pattern, with follicle-like
spaces of variable size and shape and striking cytologic
atypia [3]. In some cases, these tumors cannot be distin-
guished from each other or from other malignant tu-
mors. Recent studies of FOXL2 (forkhead box L2) gene* Correspondence: yenchein@csmu.edu.tw
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unless otherwise stated.402C > G (C134W) mutation may resolve the problems
of adult-type granulosa cell tumor diagnosis [4]. Adult-
type granulosa cell tumors are much more common and
mostly occur in perimenopausal or early postmeno-
pausal females [5].
Granulosa cell tumors are generally considered to have
a better prognosis than epithelial ovarian tumors [1].
However, there is high rate of tumor recurrence late in
life and approximately 80% of patients with advanced
stage or recurrent tumors succumb to their disease [6].
Granulosa cell tumors with malignant potential comprise
1.0 percent of all ovarian cancers [1]. The characteristics
associated with granulosa cell tumors cannot be explained
by ploidy or p53 overexpression [7,8].Case report
An 80-year-old woman presented with a clinically
detectable pelvic mass. She subsequently underwent
laparotomy for total hysterectomy and bilateral salpingo-
oophorectomy. Gross examination demonstrated an ovar-
ian mass with attached fallopian tube, measuring 11.0 ×
8.0 × 7.0 cm, which was brownish in color and elastic. Onl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Granulosa cell tumor: Histological cross-section after hematoxylin and eosin staining shows the adult granulosa cell
tumor component.
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scopically, the ovary revealed a granulosa-theca cell
tumor characterized by granulosa cells in trabecular or
cylindrical pattern and theca cells in spindle pattern
(Figure 1). FIGO stage IA was supported by pathological
report. Her blood inhibin A and B levels were 47.208 pg/ml
and 92.473 pg/ml, respectively, immediately after operation
and 15.533 pg/ml and 22.331 pg/ml, respectively, one
month post-operation. No recurrent disease was noted
during 3-year post-operation follow-up period. The
Institutional Review Board of Chung Shan Medical
University Hospital approved all procedures and informed
consent was obtained prior to collecting her genetic ma-
terial for the study.
We tested for the presence of FOXL2 402C > G muta-
tion using PCR and direct sequencing according to the
methods described by Schrader et al [9]. The nucleotideFigure 2 Replication error was detected on analysis of the CAG repea
DNA from tumor (B) is compared with DNA from normal cells (A) from thesequence analysis of FOXL2 from the granulosa cell
tumor section revealed heterozygous 402C > G mutation.
In contrast, FOXL2 sequences of genomic DNA isolated
from the blood and normal tissue of this patient did not
demonstrate this mutation. When compared with DNA
from normal cells (Figure 2A), DNA replication error
caused by slippage between the replication apparatus
and the DNA template was detected in the granulosa cell
tumor (Figure 2B), on analysis of the lengths of CAG re-
peats in androgen receptor gene, using published primers
and experimental conditions [10]. In addition, we com-
pared the DNA profiles of normal tissue and tumor tissue
using short tandem repeats (STR) analysis according to
the methods described by Wang et al [11]. The tumor
showed loss of heterozygosity (LOH) for a number of
markers (Figure 3 and Table 1). Moreover, based on array
comparative genomic hybridization (CGH), pathologicalts in androgen receptor gene by capillary gel electrophoresis.
same patient.
Wang and Lai Journal of Ovarian Research 2014, 7:88 Page 3 of 5
http://www.ovarianresearch.com/content/7/1/88genetic imbalances were detected in the tumor on Cyto-
Chip Oligo Array (BlueGenome): monosomy 4 and 10;
partial monosomy 14 with segmental deletions; and mo-
saic trisomy 6, 11, 12, 13, 15, and 18 with segmental du-
plications (Figure 4 and Table 2).
Discussion
Recent studies have shown that FOXL2 402C > G is a
diagnostic characteristic of adult-type granulosa cell
tumor [4]. However, little is known about how a granu-
losa cell tumor undergoes indolent course with late re-
current behavior [12]. We report a case of adult-type
granulosa cell tumor with FOXL2 402C > G mutation in
an 80-year-old woman, in which one allele was normal
and one was mutant. This mutation was not observed inFigure 3 LOH for a number of markers: Selective electrophoregram o
repeats (STR) analysis with AmpFlSTR SGM Plus PCR amplification kit
D8S1179, D21S11, D7S820, and CSF1PO; (B) STR loci of D19S433 and vWA;the blood and normal tissue samples of this patient.
Histological diagnosis is compatible with adult-type gran-
ulosa cell tumor in this case. RNA transcription arrays
from granulosa cell tumor cell line have indicated that al-
teration involves cell death, proliferation and tumorigen-
esis [13]. However, the mechanism is not clear.
DNA replication error on analysis of the lengths of
CAG repeats in androgen receptor gene (Figure 2B) is
consistent with a previous study suggesting that a DNA
mismatch repair deficiency contributes to the pathogen-
esis of granulosa cell tumors, and that this deficiency is an
early event in their development and/or progression [14].
LOH for a number of markers (Table 1 and Figure 3) and
pathological genetic imbalances throughout the genome
(Table 2 and Figure 4) imply that a defective upstreamf the DNA profiles of blood and tumor tissue using short tandem
. Colored panels are representative of the following: (A) STR loci of
(C) STR loci of D3S1358 and D2S1338.
Table 1 Loss of heterozygosity in 15 STR loci of the
granulosa cell tumor
STR Loci Location Alleles Ra
TPOX 2p23-2per 8, 8 ND
D2S1338 2q35-37.1 22, 23 1.63b
D3S1358 3p21.31 15, 16 1.84b
FGA 4q28 22, 23 1.01
D5S818 5q21-31 11, 11 ND
CSF1PO 5q33.3-34 10, 11 1.86b
D7S820 7q11.21-22 10, 12 0.56b
D8S1179 8q24.1-24.2 11, 11 ND
TH01 11p15.5 9, 9 ND
vWA 12p12-pter 14, 18 1.14
D13S317 13q22-31 10, 13 0.94
D16S539 16q24-qter 9, 11 1.11
D18S51 18q21.3 14, 18 1.06
D19S433 19q12-13.1 13, 14 1.81b
D21S11 21q11.2-q21 30, 31.2 2.12b
aR = (area T1/area T2)/(area N1/area N2); bLoss of heterozygosity (LOH) is
positive when R ≥ 1.25 or ≤ 0.8 (ie., 20% change).
Table 2 The deleted or duplicated clones and their
physical location in the granulosa cell tumor
ISCN nomenclature Type Size (bp)
1 arr 4p16.3q35.2(37,152-190,896,645)×1 LOSS 190,859,493
2 arr 6p25.3q27(163,113-170,921,060)×2 ~ 3 GAIN 170,757,947
3 arr 10p15.3q26.3(136,391-135,434,149)×1 LOSS 135,297,758
4 arr 11p15.5q25(196,990-134,868,378)×2 ~ 3 GAIN 134,671,388
5 arr 12p13.33q24.33(230,451-133,773,499)×2 ~ 3 GAIN 133,543,048
6 arr 13q12.11q34(20,407,324-115,092,619)×2 ~ 3 GAIN 94,685,295
7 arr 14q11.2q32.33(20,608,246-107,287,476)×1 LOSS 86,679,230
8 arr 15q11.1q26.3(20,686,219-102,383,444)×2 ~ 3 GAIN 81,697,225
9 arr 16q11.2q24.3(46,500,771-90,148,364)×1 ~ 2 LOSS 43,647,593
10 arr 18p11.32q23(148,993-78,012,800)×2 ~ 3 GAIN 77,863,807
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http://www.ovarianresearch.com/content/7/1/88regulatory gene is involved in this condition. The MLH1
gene that encodes a component of the mismatch repair
system located near the D3S1358 locus showed LOH
(Table 1). This implies that the upstream regulatory mech-
anisms leading to increased DNA replication errors, LOH,
and genetic imbalances are associated with defect(s) in
global gene regulation.
Our assumption is that a genetic alteration in mismatch
repair system occurs before FOXL2 402C >G mutation.
After this mutation is initiated, granulosa cell tumor de-
velops in early tumorigenesis. The genomic imbalances on
array CGH in this study were inconsistent with the resultsFigure 4 Array comparative genomic hybridization (aCGH) analysis: W
(CytoChip Oligo Array) shows pathological genetic imbalances in manof other array and CGH studies [15]. However, there was
a similar trend of genetic imbalances with a loss of 16q.
These genetic imbalances may contribute to late tumori-
genesis. Our hypothesis is that a DNA repair system
failure induces FOXL2 402C > G mutation, followed by
granulosa cell tumor development. The same mechan-
ism randomly causes further mutations of tumor sup-
pressor genes or oncogenes, resulting in late recurrence
and unpredictable malignant behavior of granulosa cell
tumor. However, we cannot dismiss the possibility that
the amino acid changing mutation in FOXL2 402C > G
is the driver mutation that leads to subsequent genomic
alterations in granulosa cell tumor pathogenesis.
Conclusions
Adult-type granulosa cell tumors are associated with
FOXL2 402C > G mutation. In addition to this unique
FOXL2 mutation, we found DNA replication error and
loss of heterozygosity in this case. DNA mismatch repairhole genome view on comparative genomic hybridization array
y chromosomes in the tumor.
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http://www.ovarianresearch.com/content/7/1/88system failure appears likely in this patient. In such a
case, early detection allows for treatment of benign tumor.
Although this study could not elucidate the exact mechan-
ism for the development of granulosa cell tumor, it does
suggest the need to incorporate DNA mismatch repair
system examination into the clinical management of pa-
tients with granulosa cell tumor.
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